US Broker Ratings

Elevance Health, Inc. (ELV) Stock Analysis: A Potential 14% Upside for Investors

Elevance Health, Inc. (NYSE: ELV), a major player in the healthcare sector, presents a compelling investment opportunity for those looking to capitalize on its robust market positioning and promising growth..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A Healthcare Giant with Solid Buy Ratings and a 4.82% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a titan in the healthcare sector, specifically within the diagnostics and research industry. Boasting a formidable market capitalization of $221.98 billion, the..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Look at its Market Leadership and Growth Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG), a pioneer in the field of robotic-assisted surgery, continues to capture investor attention with its robust market presence and innovative product offerings. The company, headquartered..

Eli Lilly (LLY) Stock Analysis: Navigating Through Growth with a Robust Portfolio and Strategic Collaborations

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, commands a formidable market capitalization of $964.11 billion, reflecting its robust presence in the pharmaceutical industry. The company’s..

Abivax SA (ABVX) Stock Analysis: Navigating Growth Amidst a $9.79 Billion Market Cap

For investors eyeing the biotechnology space, Abivax SA (ABVX) presents a compelling case with its innovative approach to treating chronic inflammatory diseases. Headquartered in Paris, this clinical-stage biotech firm is..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Why Analysts Predict a 74.99% Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors and analysts alike as it continues to make strides in the biotechnology sector. With a market capitalization of $1.4..

Tourmaline Bio, Inc. (TRML) Stock Analysis: A Biotech Player with a Strategic Focus on Autoimmune Innovations

Tourmaline Bio, Inc. (NASDAQ: TRML) stands as a notable presence in the biotechnology sector, focused on pioneering treatments for immune and inflammatory diseases. With a market capitalization of $1.23 billion,..

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Growth Story with Impressive Revenue Surge

Septerna, Inc. (SEPN), a dynamic player in the biotechnology sector, has captivated investor interest with its remarkable financial performance and innovative approach to tackling complex diseases. Based in South San..

Oruka Therapeutics, Inc. (ORKA)

⚠️ No article content returned.

..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Biotech with 465% Potential Upside

For investors keen on the biotechnology sector, Cel-Sci Corporation (CVM) presents a captivating opportunity. Trading on the healthcare-focused biotechnology sector, this Virginia-based company is making waves with its distinct approach..

Humacyte, Inc. (HUMA)

⚠️ No article content returned.

..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a 225% Potential Upside in the Healthcare Sector

COMPASS Pathways Plc (NASDAQ: CMPS) is drawing attention from investors with its ambitious efforts to revolutionize mental health treatment. The company, headquartered in London, operates in the burgeoning field of..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Potential 11% Upside in the Biotech Sector

Zenas BioPharma, Inc. (NASDAQ: ZBIO) may not yet be a household name, but its recent performance and future prospects are making waves in the biotechnology sector. With a current market..

LifeMD, Inc. (LFMD) Stock Analysis: An Attractive 140.89% Potential Upside for Investors

LifeMD, Inc. (NASDAQ: LFMD), a prominent player in the healthcare sector, offers investors a compelling opportunity with a substantial potential upside of 140.89%. Specializing in the health information services industry,..

Capricor Therapeutics (CAPR) Stock Analysis: A 298.84% Upside Potential Amid Phase 3 Trials

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing the attention of investors with a noteworthy potential upside of 298.84%, positioning itself as a compelling opportunity in the biotechnology sector. Headquartered in..

AngioDynamics, Inc. (ANGO) Stock Analysis: A 50% Upside Potential in the Healthcare Sector

AngioDynamics, Inc. (NASDAQ: ANGO) is capturing investor attention with its promising potential for stock appreciation, especially highlighted by a significant upside of over 50% based on current analyst target prices...

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 56.83% Upside for Healthcare Investors

Investors in the healthcare sector might want to take a closer look at Organogenesis Holdings Inc. (NASDAQ: ORGO), a company making strides in regenerative medicine. With a market cap of..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a 45% Potential Upside in Biotechnology

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company headquartered in Carlsbad, California, has been generating significant interest among investors, particularly due to its promising developments in precision medicine. Specializing..

Celcuity Inc. (CELC) Stock Analysis: Unveiling a 3.19% Potential Upside Amidst Biotechnology Advances

Celcuity Inc. (NASDAQ: CELC) presents a compelling opportunity for investors keen on the biotechnology sector. As a clinical-stage biotech firm, Celcuity is dedicated to developing targeted therapies for solid tumors,..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Challenges with 15.1% Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specifically within the medical care facilities industry, is making strides with its unique Program of All-Inclusive Care for..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds